Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tripterygium Capsule for Early Ankylosing Spondylitis
NCT00889694Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of Tripterygium wilfordii in ankylosing spondylitis (AS) (3 arms), sponsored by Sun Yat-sen University. Primary endpoint: Assessment of SpondyloArthritis international Society 20% response at 12 weeks. Status: unknown.
02
Drugs
Tripterygium wilfordii
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00889694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00889694.